OCX logo

OncoCyte (OCX) Current Assets

Annual Current Assets

$10.70 M
-$14.84 M-58.11%

December 31, 2023


Summary


Performance

OCX Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherOCXbalance sheetmetrics:

Quarterly Current Assets

$4.79 M
-$5.17 M-51.92%

September 30, 2024


Summary


Performance

OCX Quarterly Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherOCXbalance sheetmetrics:

Current Assets Formula

Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets

OCX Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-58.1%-71.7%
3 y3 years+15.9%-90.3%
5 y5 years+23.8%-90.3%

OCX Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-72.7%at low-90.3%at low
5 y5-year-72.7%+15.9%-92.4%at low
alltimeall time-72.7%+193.0%-92.4%+31.3%

OncoCyte Current Assets History

DateAnnualQuarterly
Sep 2024
-
$4.79 M(-51.9%)
Jun 2024
-
$9.97 M(+52.5%)
Mar 2024
-
$6.54 M(-38.9%)
Dec 2023
$64.19 M(-13.9%)
$10.70 M(-36.8%)
Sep 2023
-
$16.92 M(-19.4%)
Jun 2023
-
$20.98 M(+34.1%)
Mar 2023
-
$15.65 M(-38.7%)
Dec 2022
$74.56 M(-38.1%)
$25.54 M(-30.3%)
Sep 2022
-
$36.64 M(-25.8%)
Jun 2022
-
$49.37 M(+100.5%)
Mar 2022
-
$24.62 M(-37.1%)
Dec 2021
$120.42 M(+160.7%)
$39.14 M(-17.8%)
Sep 2021
-
$47.59 M(-4.8%)
Jun 2021
-
$49.99 M(-20.4%)
Mar 2021
-
$62.82 M(+580.9%)
Dec 2020
$46.19 M(+173.3%)
$9.23 M(-22.9%)
Sep 2020
-
$11.97 M(-35.1%)
Jun 2020
-
$18.45 M(+1.7%)
Mar 2020
-
$18.14 M(-21.0%)
DateAnnualQuarterly
Dec 2019
$16.90 M(+1829.6%)
$22.96 M(+13.2%)
Sep 2019
-
$20.28 M(-45.3%)
Jun 2019
-
$37.06 M(-9.6%)
Mar 2019
-
$40.99 M(+374.3%)
Dec 2018
$876.00 K(-48.1%)
$8.64 M(-27.4%)
Sep 2018
-
$11.90 M(+4.3%)
Jun 2018
-
$11.40 M(-18.9%)
Mar 2018
-
$14.05 M(+64.8%)
Dec 2017
$1.69 M(-3.6%)
$8.53 M(-31.7%)
Sep 2017
-
$12.48 M(+21.6%)
Jun 2017
-
$10.27 M(-23.7%)
Mar 2017
-
$13.45 M(+6.0%)
Dec 2016
$1.75 M(-3.0%)
$12.70 M(-16.9%)
Sep 2016
-
$15.28 M(+166.0%)
Jun 2016
-
$5.75 M(-27.2%)
Mar 2016
-
$7.90 M(-27.7%)
Dec 2015
$1.81 M(+13.6%)
$10.93 M(-9.2%)
Sep 2015
-
$12.03 M(+229.4%)
Dec 2014
$1.59 M(-53.7%)
$3.65 M
Dec 2013
$3.44 M
-

FAQ

  • What is OncoCyte annual total current assets?
  • What is the all time high annual current assets for OncoCyte?
  • What is OncoCyte annual current assets year-on-year change?
  • What is OncoCyte quarterly total current assets?
  • What is the all time high quarterly current assets for OncoCyte?
  • What is OncoCyte quarterly current assets year-on-year change?

What is OncoCyte annual total current assets?

The current annual current assets of OCX is $10.70 M

What is the all time high annual current assets for OncoCyte?

OncoCyte all-time high annual total current assets is $39.14 M

What is OncoCyte annual current assets year-on-year change?

Over the past year, OCX annual total current assets has changed by -$14.84 M (-58.11%)

What is OncoCyte quarterly total current assets?

The current quarterly current assets of OCX is $4.79 M

What is the all time high quarterly current assets for OncoCyte?

OncoCyte all-time high quarterly total current assets is $62.82 M

What is OncoCyte quarterly current assets year-on-year change?

Over the past year, OCX quarterly total current assets has changed by -$12.12 M (-71.67%)